The treatment of sleep disorders has been strongly impacted by the COVID-19 pandemic. When the lockdown is over, resumption of usual patient care will require precautions to limit the risk of contamination for patients and caregivers. In this document, the French Association of Otorhinolaryngology and Sleep disorders (AFSORL) and the French Society of Otorhinolaryngology (SFORL) put forward a summary of the measures for continuing the treatment of sleep apnoea syndrome in these new practice conditions. Emphasis is placed on teleconsultation, methods of nocturnal sleep studies, the conditions for treatment by continuous positive airway pressure (CPAP) ventilation, and the postponement of more invasive treatments.Le texte complet de cet article est disponible en PDF.
Keywords : Sleep apnoea, Coronavirus, COVID-19, SARS-CoV-2, Hygiene, Organisation of treatment, Otorhinolaryngology, OSAS (Obstructive Sleep Apnea Syndrome), CPAP (Continuous Positive Airway Pressure), Mandibular advancement device (MAD), Polygraph, Sleep endoscopy, Sleep disorders